Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. Carasent ASA
  6. News
  7. Summary
    CARA   NO0010123060

CARASENT ASA

(CARA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Carasent : May 25 2021 - Metodika PR

05/25/2021 | 10:47am EDT

Carasent ASA: Carasent ASA acquires Metodika AB

Press release

May 25, 2021

Carasent ASA acquires Metodika AB

Carasent ASA has acquired the Swedish company Metodika AB ("Metodika"), a leading provider of Enterprise Practice Management (EPM) solutions to independent hospitals and clinics across 10 European countries.

We are very pleased to have completed this transaction as Metodika, with its complementary market presence will expand Carasent's geographical footprint significantly by giving access to new European markets such as Denmark, Finland, UK, Germany and Italy, says Dennis Höjer, CEO of Carasent.

Metodika EPM software streamlines information management and efficiently helps its clients with handling the day-to-day operations of clinics and hospitals. The product platform also includes a tool for inpatient care that is complementary to Carasent's current offering.

  • We are impressed by the EPM solution that the Metodika team has developed and look forward to work with its robust organization of 22 highly competent employees. The tool for treatment and surgery will expand our product offering and enable us to service our clients in a new sub-segment. In summary, this transaction is well in-line with communicated strategic priorities of expanding within geographical, segment and product dimensions, he says.

Metodika has an attractive customer base of more than 50 clients across Europe. The company also has growing SaaS-business that can be further intensified under Carasent ownership.

Metodika's revenues and EBITDA were approximately SEK 28 million and SEK 2 million as per year-end 2020, with recurring revenues of approximately SEK 20 million. Metodika has delivered consistent historical organic growth, with 10% revenue and 14% recurring revenue CAGR from 2013-2020. However, through leveraging Carasent and Metodika's combined scale and product offering in existing and new markets, there are great opportunities to accelerate the growth going forward.

The purchase price will be SEK 114 million, corresponding to an enterprise value of SEK 108 million less Metodika's consolidated net cash position of SEK 6 million (the ("Purchase Price").

The transaction purchase price will be settled as follows:

  • ~80% of the Purchase Price in cash upon closing,
  • ~20% of the Purchase Price as shares in Carasent valued at a price of NOK 39.1 per share, corresponding to the 30-day VWAP at 20 May 2021 (the "Share Settlement").

Danske Bank acted as financial advisor to Carasent in connection with the transaction.

________________________________________________________________

About the companies:

Carasent ASA:

Carasent ASA was founded in 1997. In May 2018 the Swedish company Evimeria EMR AB, a company providing cloud-based medical record services to the health care industry, was acquired. In December 2020 Carasent ASA acquired the Norwegian company Avans Soma AS, a developer of leading medical record systems and IT solutions in the Norwegian health care market. Carasent's strategy is to develop and expand digitalization that helps customers in providing efficient and qualitative health care services in the Scandinavian market.

Metodika AB:

Metodika is a Swedish company developing and selling Metodika EPM, a highly competitive all in one solution for medium sized private clinics and hospitals in Europe. It was established by by Gustaf Horwitz in 1991. The company is located in Stockholm and has 22 employees.

________________________________________________________________

For further information, please contact:

Dennis Höjer, CEO Carasent ASA Phone: +46 733 28 49 22

Johan Lindqvist, Chairman Carasent ASA Phone: +46 733 550935

Disclaimer

Carasent ASA published this content on 25 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 25 May 2021 14:46:07 UTC.


ę Publicnow 2021
All news about CARASENT ASA
07/2222/7/2021 : Growth investor Vitruvian Partners invests to NOK 420 million privat..
PU
07/22CARASENT ASA : Growth investor Vitruvian Partners invests to NOK 420 million pri..
AQ
07/22Carasent ASA announced that it has received NOK 420.155987 million in funding..
CI
06/30CARASENT : Minutes for Annual Shareholder Meeting
AQ
06/29Carasent ASA Announces Board Changes
CI
06/0928/5/2021 : Evimeria & Mindler PR
PU
06/09CARASENT : AGM Calling Notice, 2021
PU
06/09CARASENT ASA : Calling Notice for Annual Shareholder Meeting
AQ
06/04CARASENT : Flagging
AQ
06/04CARASENT ASA : New share capital registered
AQ
More news
Financials
Sales 2021 145 M 16,4 M 16,4 M
Net income 2021 9,52 M 1,07 M 1,07 M
Net cash 2021 487 M 54,8 M 54,8 M
P/E ratio 2021 -
Yield 2021 -
Capitalization 2 519 M 284 M 283 M
EV / Sales 2021 14,0x
EV / Sales 2022 11,4x
Nbr of Employees 51
Free-Float 77,9%
Chart CARASENT ASA
Duration : Period :
Carasent ASA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CARASENT ASA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Last Close Price 37,80 NOK
Average target price 58,00 NOK
Spread / Average Target 53,4%
EPS Revisions
Managers and Directors
Dennis Lennart Peter H÷jer Chief Executive Officer
Leif Claes Johan Lundqvist Chairman
Shane Smith Senior Vice President-Technology
Terje Rogne Director
Ebba Asly Fahraeus Director
Sector and Competitors
1st jan.Capi. (M$)
CARASENT ASA0.53%284
ACCENTURE PLC22.46%202 854
TATA CONSULTANCY SERVICES LTD.11.19%158 049
INTERNATIONAL BUSINESS MACHINES CORPORATION13.40%127 950
INFOSYS LIMITED27.61%91 249
AUTOMATIC DATA PROCESSING, INC.17.07%88 461